These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 30703147)
1. Glycated haemoglobin threshold for dysglycaemia screening, and application to metabolic syndrome diagnosis in HIV-infected Africans. Nguyen KA; Peer N; de Villiers A; Mukasa B; Matsha TE; Mills EJ; Kengne AP PLoS One; 2019; 14(1):e0211483. PubMed ID: 30703147 [TBL] [Abstract][Full Text] [Related]
2. Combined use of fasting plasma glucose and glycated hemoglobin A1c in the screening of diabetes and impaired glucose tolerance. Hu Y; Liu W; Chen Y; Zhang M; Wang L; Zhou H; Wu P; Teng X; Dong Y; Zhou Jw; Xu H; Zheng J; Li S; Tao T; Hu Y; Jia Y Acta Diabetol; 2010 Sep; 47(3):231-6. PubMed ID: 19760291 [TBL] [Abstract][Full Text] [Related]
3. Alternative indices of glucose homeostasis as biochemical diagnostic tests for abnormal glucose tolerance in an African setting. Kengne AP; Erasmus RT; Levitt NS; Matsha TE Prim Care Diabetes; 2017 Apr; 11(2):119-131. PubMed ID: 28132763 [TBL] [Abstract][Full Text] [Related]
4. Burden of Diabetes and First Evidence for the Utility of HbA1c for Diagnosis and Detection of Diabetes in Urban Black South Africans: The Durban Diabetes Study. Hird TR; Pirie FJ; Esterhuizen TM; O'Leary B; McCarthy MI; Young EH; Sandhu MS; Motala AA PLoS One; 2016; 11(8):e0161966. PubMed ID: 27560687 [TBL] [Abstract][Full Text] [Related]
5. Screening for diabetes with HbA1c: Test performance of HbA1c compared to fasting plasma glucose among Chinese, Malay and Indian community residents in Singapore. Lim WY; Ma S; Heng D; Tai ES; Khoo CM; Loh TP Sci Rep; 2018 Aug; 8(1):12419. PubMed ID: 30127499 [TBL] [Abstract][Full Text] [Related]
6. Performance of HbA1c versus oral glucose tolerance test (OGTT) as a screening tool to diagnose dysglycemic status in high-risk Thai patients. Thewjitcharoen Y; Jones Elizabeth A; Butadej S; Nakasatien S; Chotwanvirat P; Wanothayaroj E; Krittiyawong S; Himathongkam T; Himathongkam T BMC Endocr Disord; 2019 Feb; 19(1):23. PubMed ID: 30770743 [TBL] [Abstract][Full Text] [Related]
7. Combined use of a fasting plasma glucose concentration and HbA1c or fructosamine predicts the likelihood of having diabetes in high-risk subjects. Ko GT; Chan JC; Yeung VT; Chow CC; Tsang LW; Li JK; So WY; Wai HP; Cockram CS Diabetes Care; 1998 Aug; 21(8):1221-5. PubMed ID: 9702423 [TBL] [Abstract][Full Text] [Related]
8. Undetected dysglycaemia common in primary care patients treated for hypertension and/or dyslipidaemia: on the need for a screening strategy in clinical practice. A report from EUROASPIRE IV a registry from the EuroObservational Research Programme of the European Society of Cardiology. Shahim B; Gyberg V; De Bacquer D; Kotseva K; De Backer G; Schnell O; Tuomilehto J; Wood D; Rydén L Cardiovasc Diabetol; 2018 Jan; 17(1):21. PubMed ID: 29368616 [TBL] [Abstract][Full Text] [Related]
9. Fasting plasma glucose and glycated haemoglobin in the screening of diabetes and impaired glucose tolerance. Mannucci E; Ognibene A; Sposato I; Brogi M; Gallori G; Bardini G; Cremasco F; Messeri G; Rotella CM Acta Diabetol; 2003 Dec; 40(4):181-6. PubMed ID: 14740278 [TBL] [Abstract][Full Text] [Related]
10. Time-saving screening for diabetes in patients with coronary artery disease: a report from EUROASPIRE IV. Gyberg V; De Bacquer D; Kotseva K; De Backer G; Schnell O; Tuomilehto J; Wood D; Rydén L BMJ Open; 2016 Dec; 6(12):e013835. PubMed ID: 27932342 [TBL] [Abstract][Full Text] [Related]
11. [Diagnostic value of fasting glucose, fructosamine, and glycated haemoglobin HbA(1c) with regard to ADA 1997 and who 1998 criteria for detecting diabetes and other glucose tolerance abnormalities]. Gołembiewska E Ann Acad Med Stetin; 2004; 50(1):131-8. PubMed ID: 16871752 [TBL] [Abstract][Full Text] [Related]
12. The diagnostic accuracy of HbA Chivese T; Hirst J; Matizanadzo JT; Custodio M; Farmer A; Norris S; Levitt N Diabet Med; 2022 Apr; 39(4):e14754. PubMed ID: 34854127 [TBL] [Abstract][Full Text] [Related]
13. Fasting Plasma Glucose and the HbA1c Are Not Optimal Screening Modalities for the Diagnosis of New Diabetes in Previously Undiagnosed Asian Indian Community Participants. Prakaschandra R; Naidoo DP Ethn Dis; 2018; 28(1):19-24. PubMed ID: 29467562 [TBL] [Abstract][Full Text] [Related]
14. Strategies to detect abnormal glucose metabolism in people at high risk of cardiovascular disease from the ORIGIN (Outcome Reduction with Initial Glargine Intervention) trial population. Badings EA; Dyal L; Schoterman L; Lok DJ; Stoel I; Gerding MN; Gerstein HC; Tijssen JG J Diabetes; 2011 Sep; 3(3):232-7. PubMed ID: 21631894 [TBL] [Abstract][Full Text] [Related]
15. Fasting plasma glucose and glycosylated hemoglobin in the screening for diabetes mellitus after renal transplantation. Valderhaug TG; Jenssen T; Hartmann A; Midtvedt K; Holdaas H; Reisaeter AV; Hjelmesaeth J Transplantation; 2009 Aug; 88(3):429-34. PubMed ID: 19667949 [TBL] [Abstract][Full Text] [Related]
16. Glycated haemoglobin and fasting plasma glucose tests in the screening of outpatients for diabetes and abnormal glucose regulation in Uganda: A diagnostic accuracy study. Kasujja FX; Mayega RW; Daivadanam M; Kiracho EE; Kusolo R; Nuwaha F PLoS One; 2022; 17(8):e0272515. PubMed ID: 35925994 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of performance of A1c and FPG tests for screening newly diagnosed diabetes defined by an OGTT among tuberculosis patients-a study from India. Kumpatla S; Aravindalochanan V; Rajan R; Viswanathan V; Kapur A Diabetes Res Clin Pract; 2013 Oct; 102(1):60-4. PubMed ID: 24035281 [TBL] [Abstract][Full Text] [Related]
18. Predicting dysglycaemia in patients under investigation for acute coronary syndrome. Tahrani AA; Geen J; Hanna FW; Jones PW; Cassidy D; Bates D; Fryer AA QJM; 2011 Mar; 104(3):231-6. PubMed ID: 20934980 [TBL] [Abstract][Full Text] [Related]
19. A large proportion of prediabetes and diabetes goes undiagnosed when only fasting plasma glucose and/or HbA1c are measured in overweight or obese patients. Cosson E; Hamo-Tchatchouang E; Banu I; Nguyen MT; Chiheb S; Ba H; Valensi P Diabetes Metab; 2010 Sep; 36(4):312-8. PubMed ID: 20627649 [TBL] [Abstract][Full Text] [Related]
20. Can HbA1c replace OGTT for the diagnosis of diabetes mellitus among Chinese patients with impaired fasting glucose? Yu EY; Wong CK; Ho SY; Wong SY; Lam CL Fam Pract; 2015 Dec; 32(6):631-8. PubMed ID: 26467644 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]